DOCSLIB.ORG

Active Labelers List Labeler ID Labeler Name Begin Date End Date 00002 ELI LILLY and COMPANY 01/01/1991 12/31/2078 00003 E.R

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Active Labelers List Labeler ID Labeler Name Begin Date End Date 00002 ELI LILLY and COMPANY 01/01/1991 12/31/2078 00003 E.R Kentucky Medicaid Pharmacy 3Q2011 Active Labelers List Labeler ID Labeler Name Begin Date End Date 00002 ELI LILLY AND COMPANY 01/01/1991 12/31/2078 00003 E.R. SQUIBB & SONS, INC. 01/01/1991 12/31/2078 00004 HOFFMANN-LA ROCHE 01/01/1991 12/31/2078 00005 LEDERLE LABORATORIES 01/01/1991 12/31/2078 00006 MERCK & CO., INC. 01/01/1991 12/31/2078 00007 GLAXOSMITHKLINE 01/01/1991 12/31/2078 00008 WYETH LABORATORIES 01/01/1991 12/31/2078 00009 PFIZER, INC 01/01/1991 12/31/2078 00013 PFIZER, INC. 01/01/1991 12/31/2078 00014 PFIZER, INC 01/01/1991 12/31/2078 00015 MEAD JOHNSON AND COMPANY 01/01/1991 12/31/2078 00023 ALLERGAN INC 01/01/1991 12/31/2078 00024 SANOFI-AVENTIS, US LLC 01/01/1991 12/31/2078 00025 PFIZER, INC. 01/01/1991 12/31/2078 00026 BAYER CORPORATION PHARMACEUTICAL DIV. 01/01/1991 12/31/2078 00028 NOVARTIS 01/01/1991 10/01/2011 00029 GLAXOSMITHKLINE 01/01/1991 12/31/2078 00031 A. H. ROBINS 01/01/1991 12/31/2078 00032 SOLVAY PHARMACEUTICALS, INC. 01/01/1991 12/31/2078 00037 MEDA PHARMACEUTICALS, INC. 01/01/1991 12/31/2078 00039 SANOFI-AVENTIS, US LLC 01/01/1991 12/31/2078 00045 ORTHO-MCNEIL-JANSSEN PHARMECEUTICAL, IN 01/01/1991 12/31/2078 00046 AYERST LABORATORIES 01/01/1991 12/31/2078 00049 PFIZER, INC 01/01/1991 12/31/2078 00051 UNIMED PHARMACEUTICALS, INC 10/01/1997 12/31/2078 00052 ORGANON USA INC. 01/01/1991 12/31/2078 00053 CSL BEHRING 01/01/1991 12/31/2078 00054 ROXANE LABORATORIES, INC. 01/01/1991 12/31/2078 00056 DUPONT PHARMACEUTICALS 01/01/1991 12/31/2078 00062 ORTHO-MCNEIL JANSSEN PHARMACEUTICALS 01/01/1991 12/31/2078 00064 HEALTHPOINT, LTD. 07/01/1995 12/31/2078 00065 ALCON LABORATORIES, INC. 01/01/1991 12/31/2078 00066 AVENTIS PHARMACEUTICALS, INC. 01/01/1991 12/31/2078 00067 NOVARTIS CONSUMER HEALTH, INC. 01/01/1991 12/31/2078 00068 AVENTIS PHARMACEUTICALS 01/01/1991 12/31/2078 00069 PFIZER, INC 01/01/1991 12/31/2078 00070 AVENTIS PHARMACEUTCALS 01/01/1991 12/31/2078 00071 PFIZER, INC 01/01/1991 12/31/2078 00072 WESTWOOD-SQUIBB PHARMACEUTICALS 01/01/1991 12/31/2078 00074 ABBOTT LABORATORIES 01/01/1991 12/31/2078 00075 AVENTIS PHARMACEUTICALS, INC. 01/01/1991 12/31/2078 00078 NOVARTIS 01/01/1991 12/31/2078 00083 NOVARTIS 01/01/1991 12/31/2078 00085 SCHERING CORPORATION 01/01/1991 12/31/2078 00087 BRISTOL-MYERS SQUIBB COMPANY 01/01/1991 12/31/2078 00088 AVENTIS PHARMACEUTICALS 01/01/1991 12/31/2078 00089 3M PHARMACEUTICALS 01/01/1991 12/31/2078 00091 SCHWARZ PHARMA, LLC 01/01/1991 12/31/2078 00093 TEVA PHARMACEUTICALS USA, INC. 01/01/1991 12/31/2078 00095 ECR PHARMACEUTICALS 10/01/1991 12/31/2078 00096 PERSON & COVEY, INC. 04/01/1999 12/31/2078 00113 L. PERRIGO COMPANY 04/30/2003 12/31/2078 00115 GLOBAL PHARMACEUTICAL CORPORATION 01/01/1991 12/31/2078 00116 XTTRIUM LABORATORIES, INC. 08/17/2001 12/31/2078 00121 PHARMACEUTICAL ASSOCIATES, INC. 01/01/1991 12/31/2078 00126 COLGATE ORAL PHARMACEUTICALS, INC. 01/01/1991 12/31/2078 00131 SCHWARZ PHARMA LLC 01/01/1991 12/31/2078 00132 C B FLEET COMPANY INC 01/01/1991 12/31/2078 00135 GLAXOSMITHKLINE 01/01/1995 12/31/2078 00143 WEST-WARD PHARMACEUTICAL CORP 01/01/1991 12/31/2078 00145 STIEFEL LABORATORIES, INC, 01/01/1991 12/31/2078 00149 PROCTER & GAMBLE PHARMACEUTICALS, INC. 01/01/1991 12/31/2078 00168 E FOUGERA AND CO. 01/01/1991 12/31/2078 00169 NOVO NORDISK, INC. 01/01/1991 12/31/2078 00172 IVAX PHARMACEUTICALS, INC. 01/01/1991 12/31/2078 00173 GLAXOSMITHKLINE 01/01/1991 12/31/2078 00178 MISSION PHARMACAL COMPANY 01/01/1991 12/31/2078 00182 GOLDLINE LABORATORIES, INC. 01/01/1991 12/31/2078 00185 EON LABS, INC. 01/01/1991 12/31/2078 00186 ASTRAZENECA LP 01/01/1991 12/31/2078 00187 VALEANT PHARMACEUTICALS NORTH AMERICA 01/01/1991 12/31/2078 00192 BAYER CORPORATION PHARMACEUTICAL DIV. 01/01/1991 12/31/2078 00193 BAYER HEALTHCARE DIABETES CARE 04/01/2008 00206 LEDERLE PIPERACILLIN 01/01/1991 12/31/2078 00224 KONSYL PHARMACEUTICALS, INC. 01/01/1992 12/31/2078 00225 B. F. ASCHER AND COMPANY, INC. 01/01/1991 12/31/2078 00228 ACTAVIS ELIZABETH LLC 01/01/1991 12/31/2078 00245 UPSHER-SMITH LABORATORIES, INC. 01/01/1991 12/31/2078 00256 FLEMING AND COMPANY 10/01/1991 12/31/2078 00258 INWOOD LABORATORIES INC 01/01/1991 12/31/2078 00259 MERZ PHARMACEUTICALS 01/01/1991 12/31/2078 00264 B. BRAUN MEDICAL INC. 01/01/1991 12/31/2078 00276 MISEMER PHARMACEUTICAL, INC. 07/10/2006 12/31/2078 00277 LASER PHARMACEUTICALS, LLC 01/01/1991 12/31/2078 00281 SAVAGE LABORATORIES 01/01/1991 12/31/2078 00288 FLUORITAB CORPORATION 10/01/1991 12/31/2078 00299 GALDERMA LABORATORIES, L.P. 01/01/1991 12/31/2078 00300 TAP PHARMACEUTICALS INC 01/01/1991 12/31/2078 00310 ASTRAZENECA LP 01/01/1991 12/31/2078 00327 GUARDIAN LABS DIV UNITED-GUARDIAN INC 01/01/1991 12/31/2078 00338 BAXTER HEALTHCARE CORPORATION 01/01/1991 12/31/2078 00378 MYLAN PHARMACEUTICALS, INC. 01/01/1991 12/31/2078 00406 MALLINCKRODT INC. 10/01/1991 12/31/2078 00407 GE HEALTHCARE, INC. 07/05/2011 12/31/2078 00409 HOSPIRA, INC. 10/28/2004 12/31/2078 00430 WARNER CHILCOTT LABORATORIES 01/01/1998 12/31/2078 00456 FOREST LABORATORIES, INC. 01/01/1991 12/31/2078 00462 PHARMADERM 02/06/2003 12/31/2078 00469 ASTELLAS PHARMA US, INC. 01/01/1991 12/31/2078 00472 ACTAVIS 01/01/1991 12/31/2078 00482 KENWOOD THERAPEUTICS 01/01/1991 12/31/2078 00485 EDWARDS PHARMACEUTICALS, INC. 01/01/1991 12/31/2078 00486 BEACH PRODUCTS INC 01/01/1991 12/31/2078 00487 NEPHRON PHARMACEUTICALS CORPORATION 04/01/1992 12/31/2078 00496 FERNDALE LABORATORIES INC. 01/01/1991 10/01/2011 00517 AMERICAN REGENT LABORATORIES, INC. 10/01/1991 12/31/2078 00525 PAMLAB, LLC 01/01/1991 01/01/2012 00527 LANNETT COMPANY, INC. 07/01/1994 12/31/2078 00535 GILBERT LABORATORIES 03/29/2002 12/31/2078 00536 WATSON PHARMA, INC. 01/01/1991 12/31/2078 00555 BARR LABORATORIES INC 01/01/1991 12/31/2078 00573 WYETH CONSUMER HEALTHCARE 01/01/1991 12/31/2078 00574 PADDOCK LABORATORIES, INC. 01/01/1991 12/31/2078 00575 TEVA BRANDED PHARMACEUTICAL PROD R AND 10/01/1991 12/31/2078 00590 DUPONT PHARMACEUTICALS 01/01/1991 12/31/2078 00591 WATSON PHARMA, INC. 03/29/2001 12/31/2078 00597 BOEHRINGER INGELHEIM PHARMACEUTICALS 01/01/1991 12/31/2078 00603 QUALITEST PHARMACEUTICALS, INC. 01/01/1991 12/31/2078 00615 VANGARD LABS, INC. 01/01/1991 12/31/2078 00641 BAXTER HEALTHCARE CORPORATION 01/01/1991 12/31/2078 00642 EVERETT LABORATORIES, INC. 01/01/1991 12/31/2078 00662 PFIZER-ROERIG 01/01/1991 12/31/2078 00663 PFIZER, INC 01/01/1991 12/31/2078 00677 UNITED RESEARCH LABORATORIES 01/01/1991 12/31/2078 00682 MARNEL PHARMACEUTICAL, INC. 01/01/1991 12/31/2078 00703 TEVA PARENTERAL MEDICINES INC 07/01/1992 12/31/2078 00713 G&W LABORATORIES, INC 01/01/1991 12/31/2078 00777 DISTA PRODUCTS CO DIV OF ELI LILLY & CO 01/01/1991 12/31/2078 00781 SANDOZ 01/01/1991 12/31/2078 00785 UAD LABORATORIES INC 01/01/1991 12/31/2078 00813 PHARMICS INC. 01/01/1991 12/31/2078 00832 UPSHER-SMITH LABORATORIES, INC. 01/01/1991 12/31/2078 00884 PEDINOL PHARMACAL INC 01/01/1991 12/31/2078 00904 MAJOR PHARMACEUTICALS 01/01/1991 12/31/2078 00905 PFIZER, INC 01/01/1991 12/31/2078 00941 BAXTER HEALTHCARE CORPORATION 04/01/2010 12/31/2078 00944 BAXTER HEALTHCARE 01/01/1991 12/31/2078 00955 SANOFI-SYNTHELABO INC. 01/01/1996 12/31/2078 00995 PFIZER, INC 01/01/1991 12/31/2078 00998 ALCON LABORATORIES, INC. 01/01/1991 12/31/2078 08317 ARKRAY USA 10/01/2009 08463 US DIAGNOSTICS, INC. 10/01/2009 08484 DIAGNOSTIC DEVICES 10/01/2009 08522 INFOPIA 10/01/2009 08539 BIONIME USA CORPORATION 10/01/2009 08548 SANVITA, INC. 04/01/2008 08554 AGAMATRIX, INC. 04/01/2008 08880 SHERWOOD MEDICAL 01/01/1991 12/31/2078 10019 BAXTER HEALTHCARE CORPORATION 06/28/2001 12/31/2078 10122 CORNERSTONE BIOPHARMA, INC. 04/26/2005 12/31/2078 10139 GENERAMEDIX INC. 12/09/2008 12/31/2078 10144 ACORDA THERAPEUTICS, INC. 05/27/2005 12/31/2078 10147 PATRIOT PHARMACEUTICALS, LLC. 01/13/2005 12/31/2078 10158 GLAXOSMITHKLINE 12/03/2001 12/31/2078 10267 CONTRACT PHARMACAL CORP 01/01/1991 12/31/2078 10337 DOAK DERMATOLOGICS 04/16/2002 12/31/2078 10370 ANCHEN PHARMACEUTICALS, INC. 05/14/2007 12/31/2078 10454 SOLSTICE NEUROSCIENCES, INC. 10/18/2005 12/31/2078 10542 HILLESTAD PHARMACEUTICALS 04/01/1994 12/31/2078 10572 AFFORDABLE PHARMACEUTICALS, LLC 11/01/2004 12/31/2078 10631 RANBAXY LABORATORIES INCORPORATED 07/20/2005 12/31/2078 10702 KVK-TECH, INC. 10/10/2006 12/31/2078 10768 PERRIGO PHARMACEUTICALS 12/14/2004 12/31/2078 10892 LUNSCO, INC 01/01/1991 12/31/2078 10914 BRIGHTON PHARMACEUTICALS, INC.
Load more

Recommended publications
  • Pfizer's Bourla
    No. 3985 December 13, 2019 line success and business development. “In the next two years, we need to see how the pipeline is delivering,” he said. Bourla has been outspoken that when it comes to business development, he doesn’t see a mega-merger on the hori- zon. Instead, he said he is looking to bring in mid-stage clinical development assets to complement the internal pipeline. It sounds like investors can expect the company to be active on the business development front within those guard- rails. “I want to double it,” he said of the pipeline, which includes 92 projects right now. “And, we are going to double it by bringing in a lot of innovation to comple- ment what we distribute.” The company is focusing business de- velopment on six core therapeutic areas Pfizer’s Bourla: “I Think We Forgot as well, but Bourla indicated the company will be actively building out those areas both through internal investment and What It Looks Like To Grow” external collaboration. “We’re going to be JESSICA MERRILL [email protected] active because Pfizer is a very big plane and it cannot fly with one engine,” he said. fizer Inc. CEO Albert Bourla took in July it will merge the Upjohn business Bourla highlighted Pfizer’s recent acqui- over the top leadership spot from with Mylan NV to form a new generic drug sition of the cancer specialist Array Bio- PIan Read a year ago, but has quickly company to be called Viatris GMBH. Pharma for $11.4bn as an example of the executed on big changes poised to make The resulting Pfizer will be significantly kinds of deals the company will be pursu- Pfizer significantly smaller and faster smaller, with a 2020 annual revenue base ing.
    [Show full text]
  • Health Industry Business Communications Council
    Health Industry Business Communications Council Registered Labelers: Accredited Auto-ID Labeling Standards Argentina New MedTek Devices Pty Ltd Oxavita SRL Norseld Pty Ltd. Novadien Healthcare Pty Ltd The following companies Odontit S.A. (and/or their subsidiaries/ PAMPAMED S.R.L. Numedico Technologies Pty Ltd divisions) have applied PATEJIM SRL Opto Global Pty. Ltd. for a Labeler Identification Orthocell Limited Code (LIC) assignment with Austria Prolotus Technologies Pty Ltd HIBCC*. By doing so, they afreeze GmbH Red Milawa Pty Ltd dba Magic Mobility have demonstrated their AMI GmbH SDI Limited commitment to patient safety Bender Medsystems GmbH Signostics Ltd. and logistical efficiency for BHS Technologies GmbH Sirtex Medical Pty Ltd their customers, the industry Metasys Medizintechnik GmbH Smith & Nephew Surgical Pty. Ltd. and the public at large. PAA Laboratories GmbH Staminalift International Limited Safersonic Medizinprodukte Handels The Pipette Company Pty. Ltd. Any organization that is GmbH Thermo Electron Corporation interested in using the HIBC W & H Dentalwerk Burmoos GmbH Vush Pty Ltd uniform labeling system may apply for the assignment of VUSH STIMULATION Australia one or more LICs. William A Cook Australia Pty. Ltd. Adv. Surgical Design & Manufacture, Ltd. Last updated 9-21-2021 AirPhysio Pty Ltd Belgium Annalise-AI Pty Ltd 3M Europe Apollo Medical Imaging Technology Pty Advanced Medical Diagnostics SA/NV Ltd Analis SA/NV Benra Pty Ltd dba Gelflex Laboratories Baxter World Trade Bioclone Australia Pty. Ltd. Bio-Rad RSL Candelis, Inc. Bio-Rad Lab Inc Clinical Diag. Group DePuy Australia Pty. Ltd. Biosource Europe SA For more information, please dorsaVi Ltd Cilag NV contact the HIBCC office at: EC Certification Service GmbH Coris Bioconcept Fink Engineering Pty Ltd Fuji Hunt Photographic Chemicals NV 2525 E.
    [Show full text]
  • PFIZER INC. (Exact Name of Registrant As Specified in Its Charter)
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-3619 PFIZER INC. (Exact name of registrant as specified in its charter) Delaware 13-5315170 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) 235 East 42nd Street, New York, New York 10017 (Address of principal executive offices) (zip code) (212) 733-2323 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $.05 par value PFE New York Stock Exchange 0.000% Notes due 2020 PFE20A New York Stock Exchange 0.250% Notes due 2022 PFE22 New York Stock Exchange 1.000% Notes due 2027 PFE27 New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]
  • UNITED NATIONS SYSTEM Annual Statistical Report 2005
    Annual Statistical Report 2005 • Procurement of Goods & Services • All Sources of Funding • UNDP Funding • Procurement from DAC Member Countries • International & National Project Personnel • United Nations Volunteers • Fellowships Published: July 2006 by UNITED NATIONS SYSTEM Annual Statistical Report 2005 Procurement of Goods and Services • All Sources of Funding • UNDP Funding Procurement from DAC Member Countries International & National Project Personnel United Nations Volunteers Fellowships July 2006 Copyright © 2006 by the United Nations Development Programme 1 UN Plaza, New York, NY 10017, USA All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic, photocopying, recording or otherwise, without prior permission of UNDP/IAPSO. TABLE OF CONTENTS INTRODUCTION...................................................................................................................... 1 GLOASSARY OF TERMS ...................................................................................................... 3 EXECUTIVE SUMMARY: ALL SOURCES OF FUNDING (UN SYSTEM)............................ 4 PROCUREMENT OF GOODS AND SERVICES - ALL SOURCES OF FUNDING Procurement of goods by country of procurement and services by country of head office ................................................................................................... 9 Procurement by UN agency ......................................................................................
    [Show full text]
  • FTSE Developed
    2 FTSE Russell Publications 19 August 2021 FTSE Developed Indicative Index Weight Data as at Closing on 30 June 2021 Index weight Index weight Index weight Constituent Country Constituent Country Constituent Country (%) (%) (%) 1&1 AG <0.005 GERMANY Alcon AG 0.05 SWITZERLAND Aozora Bank <0.005 JAPAN 3i Group 0.03 UNITED Ald SA <0.005 FRANCE APA Group 0.01 AUSTRALIA KINGDOM Alexandria Real Estate Equity 0.04 USA Appen <0.005 AUSTRALIA 3M Company 0.19 USA Alexion Pharm 0.07 USA Apple Inc. 3.61 USA A P Moller - Maersk A 0.02 DENMARK Alfa Laval 0.02 SWEDEN Applied Materials 0.22 USA A P Moller - Maersk B 0.03 DENMARK Alfresa Holdings <0.005 JAPAN Aptiv PLC 0.07 USA a2 Milk 0.01 NEW ZEALAND Align Technology Inc 0.08 USA Aramark 0.01 USA A2A 0.01 ITALY Alimentation Couche-Tard B 0.05 CANADA Arcelor Mittal 0.04 NETHERLANDS AAC Technologies Holdings 0.01 HONG KONG Alleghany 0.02 USA Arch Capital Gp 0.03 USA Aalberts NV 0.01 NETHERLANDS Allegion PLC 0.02 USA Archer Daniels Midland 0.06 USA ABB 0.1 SWITZERLAND Allegro 0.01 POLAND Argenx S.E 0.03 BELGIUM Abbott Laboratories 0.34 USA Alliant Energy 0.02 USA Ariake Japan <0.005 JAPAN AbbVie Inc 0.33 USA Allianz SE 0.17 GERMANY Arista Networks 0.04 USA ABC-Mart <0.005 JAPAN Allstate Corp 0.07 USA Aristocrat Leisure 0.03 AUSTRALIA Abiomed Inc 0.02 USA Ally Financial 0.03 USA Arkema 0.01 FRANCE ABN AMRO Bank NV 0.01 NETHERLANDS Alnylam Pharmaceuticals 0.03 USA Aroundtown SA 0.02 GERMANY Accenture Cl A 0.31 USA Alony Hetz Properties & Inv <0.005 ISRAEL Arrow Electronics 0.01 USA Acciona S.A.
    [Show full text]
  • Participating Labelers.Xlsx
    Labeler Labeler Effective Labeler End Code Labeler Name Date Date 00002 ELI LILLY AND COMPANY 1/1/1991 12/31/2299 00003 E.R. SQUIBB & SONS, INC. 1/1/1991 12/31/2299 00004 HOFFMANN-LA ROCHE 1/1/1991 12/31/2299 00005 LEDERLE LABORATORIES 1/1/1991 12/31/2299 00006 MERCK & CO., INC. 1/1/1991 12/31/2299 00007 GLAXOSMITHKLINE 1/1/1991 12/31/2299 00008 WYETH LABORATORIES 1/1/1991 12/31/2299 00009 PFIZER, INC 1/1/1991 12/31/2299 00013 PFIZER, INC. 1/1/1991 12/31/2299 00015 MEAD JOHNSON AND COMPANY 1/1/1991 12/31/2299 00023 ALLERGAN INC 1/1/1991 12/31/2299 00024 SANOFI-AVENTIS, US LLC 1/1/1991 12/31/2299 00025 PFIZER, INC. 1/1/1991 12/31/2299 00026 BAYER CORPORATION PHARMACEUTICAL DIV. 1/1/1991 12/31/2299 00028 NOVARTIS 1/1/1991 12/31/2299 00029 GLAXOSMITHKLINE 1/1/1991 12/31/2299 00031 A. H. ROBINS 1/1/1991 12/31/2299 00032 SOLVAY PHARMACEUTICALS, INC. 1/1/1991 12/31/2299 00037 MEDA PHARMACEUTICALS, INC. 1/1/1991 12/31/2299 00039 SANOFI-AVENTIS, US LLC 1/1/1991 12/31/2299 00045 ORTHO-MCNEIL-JANSSEN PHARMECEUTICAL, IN 1/1/1991 12/31/2299 00046 AYERST LABORATORIES 1/1/1991 12/31/2299 00049 PFIZER, INC 1/1/1991 12/31/2299 00051 UNIMED PHARMACEUTICALS, INC 10/1/1997 12/31/2299 00052 ORGANON USA INC. 1/1/1991 12/31/2299 00053 CSL BEHRING 1/1/1991 12/31/2299 00054 ROXANE LABORATORIES, INC.
    [Show full text]
  • UNITED NATIONS SYSTEM Annual Statistical Report 2005
    Annual Statistical Report 2005 • Procurement of Goods & Services • All Sources of Funding • UNDP Funding • Procurement from DAC Member Countries • International & National Project Personnel • United Nations Volunteers • Fellowships Published: July 2006 by UNITED NATIONS SYSTEM Annual Statistical Report 2005 Procurement of Goods and Services • All Sources of Funding • UNDP Funding Procurement from DAC Member Countries International & National Project Personnel United Nations Volunteers Fellowships July 2006 Copyright © 2006 by the United Nations Development Programme 1 UN Plaza, New York, NY 10017, USA All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic, photocopying, recording or otherwise, without prior permission of UNDP/IAPSO. TABLE OF CONTENTS INTRODUCTION...................................................................................................................... 1 GLOASSARY OF TERMS ...................................................................................................... 3 EXECUTIVE SUMMARY: ALL SOURCES OF FUNDING (UN SYSTEM)............................ 4 PROCUREMENT OF GOODS AND SERVICES - ALL SOURCES OF FUNDING Procurement of goods by country of procurement and services by country of head office ................................................................................................... 9 Procurement by UN agency ......................................................................................
    [Show full text]
  • Downloaded to a PC Or PDA
    DDT Issue10 NOVEMBER05 11/28/05 4:27 PM Page 1 NOVEMBER/DECEMBER 2005 Vol 5 No 10 IN THIS ISSUE Corporate Profiles 12 Drug Delivery Technologies 76 Excipients, Polymers, Liposomes & Lipids 92 Contract Pharmaceutical & Biological Development Services 98 Laboratory Testing & Analytical Equipment & Sotware 109 Technology Spotlight 113 The science & business of specialty pharma, biotechnology, and drug delivery www.drugdeliverytech.com DDT Issue10 NOVEMBER05 11/7/05 3:41 PM Page 2 NO BARRIERS. NEW FRONTIERS. COMPLEX CHALLENGES, INNOVATIVE SOLUTIONS. For 35 years, ALZA has led the drug delivery industry in developing extraordinary products based on our transdermal, oral, implantable, and liposomal delivery platforms. More than 30 products in 80 countries are based on ALZA’s novel drug delivery and targeting technologies. Today, ALZA’s dedicated researchers and scientists are addressing the complex challenges of delivering small molecules and biopharmaceuticals, with the commitment to create better medicines that improve healthcare for patients worldwide. Visit www.alza.com to learn more. © 2003 ALZA Corporation LEADING THE NEXT GENERATION OF DRUG DELIVERY DDT Issue10 NOVEMBER05 11/5/05 8:12 AM Page 3 Inhalation and transdermal technology from 3M w Novel Dry Powder Inhaler Ne Gives you the edge in a from MicroDose Technologiescompetitive environment The MicroDose dry powder inhaler, CFC-free metered dose inhaler and transdermal drug delivery systems customized to your specifications ៑ A wide variety of components to meet your needs ៑ Nearly 50 years’ experience in inhalation drug delivery technology and skin adhesion products ៑ Fully integrated development and manufacturing processes ៑ Global regulatory expertise ៑ Project management support available from concept through commercialization Developing proven solutions that enable your success.
    [Show full text]
  • 2019 MED-Project Annual Report
    2019 MED-Project Annual Report Alameda County, California March 1, 2020 Prepared By: MED-Project LLC Submitted To: Alameda County, Department of Environmental Health Table of Contents Executive Summary ............................................................................................................. 4 Participating Producers ....................................................................................................... 5 Collection Method and Weight ............................................................................................ 5 A. Kiosks .................................................................................................................................... 5 B. Mail-Back Packages ................................................................................................................. 5 C. Take-Back Events ................................................................................................................... 5 D. Total Weight of Collected Unwanted Medicine ........................................................................... 5 Kiosk Drop-Off Locations, Mail-Back Distribution, and Take-Back Events ......................... 5 Kiosk Drop-Off Locations ......................................................................................................... 6 Mail-Back Package Distribution Locations .................................................................................. 6 Number of Mail-Back Packages Provided to Home-Bound and Under Served Residents ...............
    [Show full text]
  • Drug Companies Participating in MED-Project Stewardship Plan (February 9, 2017)
    Drug Companies Participating in MED-Project Stewardship Plan (February 9, 2017) Participating Drug Company Parent Drug Company 3M Corporation 3M Corporation 3M Critical and Chronic Care 3M Corporation 3M Drug Delivery Systems 3M Corporation 3M Infection Prevention 3M Corporation 3M Oral Care 3M Corporation AbbVie Inc. AbbVie Inc. ACADIA Pharmaceuticals Inc. ACADIA Pharmaceuticals Inc. Accord Healthcare Inc. Accord Healthcare Inc. Acorda Therapeutics, Inc. Acorda Therapeutics, Inc. Acorda Therapeutics, Inc. Acorda Therapeutics, Inc. Actavis Generics Teva Pharmaceuticals USA, Inc. Actavis Pharma, Inc. (only for labeler code 52544) Allergan, Inc. Actelion Pharmaceuticals US, Inc. Actelion Pharmaceuticals US, Inc. Advanced Vision Research Inc. d.b.a. Akorn Consumer Health Akorn, Inc. Aegerion Pharmaceuticals, Inc. Aegerion Pharmaceuticals, Inc. Afaxys Inc. Afaxys Inc. Afaxys Pharmaceuticals (a division of Afaxys Inc.) Afaxys Inc. Affordable Pharmaceuticals LLC Braintree Laboratories Inc. Akorn Animal Health, Inc. Akorn, Inc. Akorn, Inc. Akorn, Inc. Akrimax Pharmaceuticals, LLC Akrimax Pharmaceuticals, LLC AKRON COATING & ADHESIVES AKRON COATING & ADHESIVES Alcon Laboratories, Inc. Novartis Group Companies Allergan Sales LLC Allergan, Inc. Allergan USA, Inc. Allergan, Inc. Allergan, Inc. Allergan, Inc. Alva-Amco Pharmacal Companies, Inc. Alva-Amco Pharmacal Companies, Inc. AMAG Pharma USA, Inc. AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals, Inc. Amarin Corp Amarin Pharma, Inc. Amarin Corp. PLC Amarin Pharma, Inc. Amarin Pharma, Inc. Amarin Pharma, Inc. Amarin Pharmaceuticals Ireland Ltd. Amarin Pharma, Inc. American Regent, Inc. Daiichi Sankyo, Inc. Amerisource Health Services Corporation DBA: American Health Amerisource Health Services Corporation DBA: American Health Packaging Packaging Amgen Inc. Amgen Inc. Amgen USA Amgen Inc. Amneal Pharmaceuticals LLC Amneal Pharmaceuticals LLC Anchen Pharmaceuticals, Inc.
    [Show full text]
  • Washington State 2020 Annual Report (PDF)
    First MED-Project Annual Report For 2019 Operating Period State of Washington Due July 1, 2020 Prepared By: MED-Project WA, LLC Submitted To: Washington State Department of Health Table of Contents I. Executive Summary ............................................................................................................... 3 II. Annual Budget ...................................................................................................................... 3 Table 1: Annual Budget .................................................................................................................. 4 Appendix A ................................................................................................................................ 5 List of Covered Manufacturers ......................................................................................................... 5 Table 2: List of Covered Manufacturers.......................................................................................... 21 2 I. Executive Summary MED-Project WA, LLC’s (“MED-Project”) Product Stewardship Plan for Covered Drugs from Households (“Plan”) was approved by the Washington State Department of Health (the "Department") on May 25, 2020. Per the Plan, MED-Project will initiate operations by November 21, 2020, which is within 180 days of the Plan approval date. This first Annual Report for the 2019 reporting period was requested by the Department and includes an update to the annual budget that occurred after the submission of the proposed Plan and
    [Show full text]
  • MED-Project Participating Drug Companies - King County Washington, March 2020
    MED-Project Participating Drug Companies - King County Washington, March 2020 Drug Company Name Parent Company 3M Corporation 3M Corporation 3M Drug Delivery Systems 3M Corporation 3M ESPE 3M Corporation 3M Health Care 3M Corporation 3M Personal Care 3M Corporation AbbVie Inc. AbbVie Inc. ACADIA Pharmaceuticals Inc. ACADIA Pharmaceuticals Inc. Accord Healthcare Inc. Accord Healthcare Inc. Acorda Therapeutics, Inc. Acorda Therapeutics, Inc. Acorda Therapeutics, Inc. Acorda Therapeutics, Inc. Actavis Generics Teva Pharmaceuticals USA, Inc. Actavis Pharma, Inc. (only for labeler code 52544) Allergan, Inc. Actelion Johnson & Johnson Adapt Pharma Inc. Adapt Pharma Inc. Advanced Vision Research Inc. d.b.a. Akorn Consumer Health Akorn, Inc. Advantice Health Advantice Health Aegerion Pharmaceuticals, Inc. Aegerion Pharmaceuticals, Inc. Afaxys Inc. Afaxys Inc. Afaxys Pharmaceuticals (a division of Afaxys Inc.) Afaxys Inc. Affordable Pharmaceuticals LLC Sebela Pharmaceuticals Inc. Ajanta Pharma USA Inc. Ajanta Pharma USA Inc. AkaRx, Inc., dba Dova Pharmaceuticals AkaRx, Inc., dba Dova Pharmaceuticals Akebia Therapeutics, Inc. Akebia Therapeutics, Inc. Akorn Animal Health, Inc. Akorn, Inc. Akorn, Inc. Akorn, Inc. Akrimax Pharmaceuticals, LLC Akrimax Pharmaceuticals, LLC AKRON COATING & ADHESIVES AKRON COATING & ADHESIVES Alaven Pharmaceuticals LLC Mylan Inc. Alcon Laboratories, Inc. Novartis Group Companies Alembic Pharmaceuticals Inc. Alembic Pharmaceuticals Inc. Allergan Sales, LLC Allergan, Inc. Allergan USA, Inc. Allergan, Inc. Allergan, Inc. Allergan, Inc. Almaject, Inc. Alvogen Pharma US, Inc. Almatica Pharma, Inc. Alvogen Pharma US, Inc. Almirall LLC Almirall LLC Alphapharm Pty Ltd Mylan Inc. Alva-Amco Pharmacal Companies, Inc. Alva-Amco Pharmacal Companies, Inc. Alvogen Pharma US, Inc. Alvogen Pharma US, Inc. Alvogen, Inc. Alvogen Pharma US, Inc. AMAG Pharma USA, Inc.
    [Show full text]